RLMD relmada.com Yakuniy foyda

RLMD (relmada.com) - kompaniyaning tovar belgisi

Relmada Therapeutics (RLMD) depressiyaning og'ir shakllari bilan kurashish uchun innovatsion NMDA retseptorlari antagonistini ishlab chiqmoqda. Kompaniyaning sof foydasi kapital to'planish dinamikasini aks ettiradi va bunda parametr -0.06 darajasida barqarorlashgan. Xarajatlarni optimallashtirish tadqiqot va ishlab chiqarishni autsorsing qilish orqali amalga oshirilmoqda. Pudratchilarning texnik imkoniyatlarini modernizatsiya qilish dori vositalarining barqaror ishlab chiqarilishini va laboratoriyalarning uzluksiz ishlashini ta'minlaydi.

Kompaniyaning sof foydasi: Relmada Corp (RLMD) 04.07.2022 - 29.10.2026 uchun
Relmada Therapeutics, Inc. asosiy tovari

Kapitalni optimallashtirish uchun operatsion xarajatlar va real daromadlar o'rtasida muvozanatni topish muhimdir, ayniqsa, istiqbollari psixiatrlar ishonchiga bog'liq bo'lgan Relmada Therapeutics (RLMD) kompaniyasi uchun. Kompaniyaning balans foydasini kunlik sof daromad dinamikasi orqali tahlil qilish biznes rivojlanish momentumini aniqlash imkonini beradi, bunda haddan tashqari yuqori foyda cho'qqilari aktivning haddan tashqari qiziganini ko'rsatishi mumkin, barqaror tendentsiya esa fundamental barqarorlikni tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|RGC: Yakuniy foyda|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Viking Therapeutics Corp - Kompaniyaning sof foydasi|SUPN - Kompaniyaning sof foydasi|catalystpharma.com (CPRX) - Sof daromad|DNLI: Sof foyda|Harmony Biosciences Inc (HRMY) - Sof foyda|BHVN (Biohaven Pharmaceutical) - Sof foyda|Kompaniya foydasi AMLX (Amylyx Corp)|Sof foyda TRVI|Sof foyda praxismedicines.com (PRAX)|Anavex Life Sciences Corp. - Sof daromad|Yakuniy foyda CBLL|PRTA: Sof daromad|Alector, Inc. - Soliqlar to‘langandan keyingi foyda|ANNX: Sof foyda|Omeros - Yakuniy foyda|NGNE (Neurogene) - Sof foyda|Kompaniyaning sof daromadi AC Immune S.A. ACIU|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|NMRA (Neumora Corp) - Yakuniy foyda|Sof foyda SCLX (Scilex Holding Company)|Sof foyda tevogen.com TVGN|ACOG - Kompaniyaning sof foydasi|Soliqdan keyingi foyda CGTX|IKT: Sof foyda|Kompaniyaning sof daromadi Cassava Pharma (SAVA)|Sof daromad ASRT|Sof foyda Coya|Sof daromad VTGN (Vistagen Therapeutics)|Soliqlar to‘langandan keyingi foyda OVID|Sof foyda ABOS (Acumen Pharma)|Sof moliyaviy natija CervoMed Corporation (CRVO)|Alterity Therapeutics Ltd - Sof foyda|Clene Inc. (CLNN) - Sof daromad|pepgen.com (PEPG) - Kompaniyaning sof foydasi|JUNS - Sof moliyaviy natija|Kompaniyaning sof foydasi Annovis Bio Corp|GRCE: Yakuniy foyda|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|Kompaniyaning sof foydasi KLTO (anewmeds.com)|Kompaniyaning sof foydasi NeuroSense Therapeutics Ltd. NRSN|RVPH - Sof daromad|MetaVia, Inc. - Sof foyda|NRXS (NeurAxis Inc) - Kompaniya foydasi|heliusmedical.com (HSDT) - Kompaniyaning sof foydasi|Kompaniya foydasi PASG|NEUP (Neuphoria Therapeutics, Inc.) - Sof foyda|Kompaniyaning sof daromadi Minerva Neurosciences Inc NERV|Sof daromad ATHA (Athira)|Sof foyda Addex (ADXN)|Kompaniyaning sof foydasi Alzamend Neuro ALZN|Yakuniy foyda CYCN|PTIX - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Pasithea Therapeutics|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Avenue Therapeutics Inc - Yakuniy foyda|BCLI (Brainstorm Cell) - Sof foyda|Kompaniyaning sof daromadi caratherapeutics.com CARA|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|Kompaniyaning sof foydasi ELYM (eliemtx.com)|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|LBPH - Sof daromad|Marinus Pharmaceuticals - Sof foyda|NKGN - Sof foyda|NRBO: Sof foyda|Kompaniya foydasi SAGE|SNPX (Neurotrope) - Sof foyda|Sof foyda Trevena Inc|Sof daromad VIGL (Vigil Neuroscience)|WENA (Anew Medical Inc.) - Yakuniy foyda|Cerevel Therapeutics, Inc. - Sof daromad